Danaos CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NYSE
DAC
Danaos CORPDanaos Corporation's latest Schedule 13D/A filing reveals an updated beneficial ownership of 51.8% for Dr. John Coustas and the 883 Trust, reflecting recent equity awards and share acquisitions.
NYSE
DAC
Danaos CORPSCHEDULE 13D/A: Danaos Corporation's Controlling Shareholder Updates Ownership Stake to 50.5% Following Company Share Repurchases
An amendment to a Schedule 13D filing reveals that Danaos Investment Limited, as Trustee of the 883 Trust, and Dr. John Coustas, now beneficially own 50.5% of Danaos Corporation's common stock, primarily due to the company's share repurchase program.
NYSE
DAC
Danaos CORPSCHEDULE 13D/A: Danaos Corporation: Major Shareholder's Stake Rises to 49.4% Following Company Share Repurchases
An amendment to a Schedule 13D filing reveals that Danaos Investment Limited, as Trustee of the 883 Trust, and Dr. John Coustas now beneficially own 49.4% of Danaos Corporation's common stock, primarily due to the company's ongoing share repurchase program.